The evaluation of novel mixed metal hydroxy-carbonates as phosphate binders: An in-vivo study in the rat

Journal of Pharmacy and Pharmacology

Volumn 53, Issue 4, 2001, Pages 513-519

  Rankin, B J ^a   Thewles, A ^b   Lote, C J ^b   Webb, M ^c   Roberts, N B ^a  

^a ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c Crosfield Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; CALCIUM CARBONATE; CALCIUM DERIVATIVE; HYDROTALCITE; IRON COMPLEX; MAGNESIUM DERIVATIVE; MAGNESIUM HYDROXIDE; MIXED METAL HYDROXYCARBONATE; PHOSPHATE; PHOSPHATE BINDING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ARTICLE; BINDING KINETICS; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG BINDING; DRUG EFFICACY; DRUG SCREENING; EVALUATION; FECES ANALYSIS; IN VIVO STUDY; METABOLIC PARAMETERS; METAL METABOLISM; NONHUMAN; PHOSPHATE METABOLISM; PHOSPHATE URINE LEVEL; RAT; STANDARD; STRUCTURE ANALYSIS;

ANIMALS; CARBONATES; HYDROXIDES; IRON; METALS; PHOSPHATES; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0035038788     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357011775613     Document Type: Article

References (27)

1. The dialysis encephalopathy syndrome: Possible aluminium intoxication
2. Overview and mechanisms of iron regulation
3. Control of serum phosphorus in uremia
4. Adaptation in iron metabolism
5. Accumulation of aluminium in patients with acute renal failure
6. Lanthanum carbonate an effective inhibitor of phosphate absorption form the gastrointestinal tract
7. Management of hyperphospahtaemia in patients with renal failure
8. A possible non-aluminium oral phosphate binder? A comparative study on dietary phosphorus absorption
9. Reduction of dietary phosphorus absorption by oral phosphorus binders
10. The use of magnesium-containing phosphate binders in patients with end stage renal disease on maintenance haemodialysis
11. Hyperphosphataemia and hypophosphataemia
12. Absorption and excretion of iron
13. Substitution of aluminium salts by magnesium salts in control of dialysis hyperphosphataemia
14. Long term use of magnesium hydroxide as a phosphate binder in patients on haemodialysis
15. Hydrotalcites as potential absorbents of intestinal phosphate
16. Fracturing dialysis osteodystrophy and dialysis encephalopathy
17. Calcium acetate versus calcium carbonate as phosphate-binding agents in chronic haemodialysis
18. The chemistry of aluminium in the gastrointestinal lumen and it's uptake and absorption
19. Investigations into new phosphate binders
20. Synthesis of anionic clay materials (mixed metal hydroxides, hydrotalcite)
21. Haematologic consequences of renal failure
22. Treatment of uremic hyperphosphataemia - Is there still a need for aluminium salts
23. Aluminium- Much ado about something
24. Reversible microcytic hypochromic anaemia in dialysis patients due to aluminium intoxication
25. Cross-linked iron dextran is an efficient oral phosphate binder in the rat
26. Intestinal absorption of aluminium from antacids: A comparison between hydrotalcite and algeldrate